These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date||2014-005613-24||Intrathecal administration (pattern 100/3) of expanded autologous adult bone marrow mesenchymal troncal cells in established chronic spinal cord injuries||bad-data|
|Completed, but no date||2015-002383-16||Evaluate the efficacy of the cell therapy with NC1 medication in patients with post-traumatic syringomyelia||bad-data|
|Ongoing||2015-003940-38||Plasma level pharmacokinetics study of posaconazole with the sequential use of two oral formulations (oral suspension and solid tablets) in haematology patients with a high risk of invasive mycoses.||not-yet-due|
|Ongoing||2016-000623-73||LIDOCAINE IN ISCHEMIA-REPERFUSION INJURY FROM MICROSURGICAL BREAST RECONSTRUCTION. RANDOMISED UNICENTRIC, DOUBLE-BLIND, CLINICAL, CONTROLLED TRIAL.||not-yet-due|
|Ongoing||2017-001824-23||Intrathecal administration of autologous adult bone marrow mesenchymal stem cells expanded in the diffuse axonal injury.||not-yet-due|
|Ongoing||2019-002057-34||A RANDOMISED, DOUBLE-BLIND CONTROLLED TRIAL TO EVALUATE THE EFFICACY OF INTRACAVERNOSAL INFUSION OF PLATELET RICH PLASMA (PRP) AGAINST PLATELET POOR PLASMA (PPP) IN THE TREATMENT OF VASCULOGENIC ERECT...||not-yet-due|